Cash & equivalents increased 334.5%
Cash & equivalents changed +334.5% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +334.5% from the comparable as-filed period.
Debt changed +1043.4% from the comparable as-filed period.
Gross profit changed +113.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed +18871 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Research & development changed -37.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed +104.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed -51.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +15.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating income changed +12.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross margin changed +139 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.